These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30596268)

  • 1. Clinical Significance of Prognostic Nutritional Index for Patients with Diffuse Large B-cell Lymphoma.
    Yu W; Guo Q; Wang Z; Mao L; Wei J; Jin J; Wang J
    Nutr Cancer; 2019; 71(4):569-574. PubMed ID: 30596268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geriatric nutritional risk index is not an independent predictor in patients with diffuse large B-cell lymphoma.
    Li Z; Guo Q; Wei J; Jin J; Wang J
    Cancer Biomark; 2018; 21(4):813-820. PubMed ID: 29504524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma.
    Go SI; Park S; Kang MH; Kim HG; Kim HR; Lee GW
    Ann Hematol; 2019 Feb; 98(2):401-411. PubMed ID: 30413902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Zhou Q; Wei Y; Huang F; Wei X; Wei Q; Hao X; Zhang Y; Feng R
    Int J Hematol; 2016 Oct; 104(4):485-90. PubMed ID: 27393279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma.
    Periša V; Zibar L; Knezović A; Periša I; Sinčić-Petričević J; Aurer I
    Wien Klin Wochenschr; 2017 Jun; 129(11-12):411-419. PubMed ID: 27637206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group.
    Ma S; Zhang B; Lu T; Li D; Li T; Shen Z; He C; Wang Y; Li B; Zhang H; Gu W; Wang C; Ye J; Zhu T; Miao Y; Wang L; Huang S; Liu Q; Sang W;
    Cancer; 2022 Oct; 128(19):3487-3494. PubMed ID: 35932292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.
    Matsukawa T; Suto K; Kanaya M; Izumiyama K; Minauchi K; Yoshida S; Oda H; Miyagishima T; Mori A; Ota S; Hashimoto D; Teshima T;
    Ann Hematol; 2020 Dec; 99(12):2859-2868. PubMed ID: 32970194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison and exploration of the prognostic value of the advanced lung cancer inflammation index, prognostic nutritional index, and systemic immune-inflammation index in newly diagnosed diffuse large B-cell lymphoma.
    Liu T; Ye F; Li Y; Liu A
    Ann Palliat Med; 2021 Sep; 10(9):9650-9659. PubMed ID: 34628890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
    Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
    Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era.
    Nakayama S; Matsuda M; Adachi T; Sueda S; Ohashi Y; Awaji S; Hashimoto S; Matsumura I
    Platelets; 2019; 30(5):637-645. PubMed ID: 30047815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
    Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
    Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of inflammatory parameters and nutritional index in clinical stage IVB endometrial carcinomas.
    Kiuchi K; Hasegawa K; Ochiai S; Motegi E; Kuno T; Kosaka N; Fukasawa I
    J Obstet Gynaecol; 2019 Feb; 39(2):237-241. PubMed ID: 30370797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.
    Lu TX; Wu S; Cai DY; Hong TT; Zhang Y; Gao HQ; Hua HY; Wu XH
    BMC Cancer; 2019 Jun; 19(1):553. PubMed ID: 31176361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
    Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Useful prognostic tools based on complete blood cell counts in diffuse large B-cell lymphoma.
    Shimono J; Takahashi S; Takemura R; Kakinoki Y
    Int J Lab Hematol; 2019 Dec; 41(6):754-761. PubMed ID: 31529774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
    Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
    J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
    Yao N; Hou Q; Zhang S; Xiao H; Liang Y; Xu X; Guo R; Li H; Lan S; Si H; Cao J
    Front Oncol; 2020; 10():877. PubMed ID: 32637354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 20. High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.
    Chang C; Wu SY; Kang YW; Lin KP; Chen TY; Medeiros LJ; Chang KC
    Am J Clin Pathol; 2015 Dec; 144(6):935-44. PubMed ID: 26573001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.